πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11027007

Recombinant metapneumovirus F proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11028152

Single domain antibodies to Chikungunya virus

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11027008

Recombinant mumps virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11021545

Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer

The Regents of the University of California Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11020470

Virus-like particles

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11020409

Broad antiviral therapy with membrane modifying oxysterols

The Regents of the University of California Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013798

Orf virus-based platform for vaccine delivery

SOUTH DAKOTA BOARD OF REGENTS Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013774

Methods of heat inactivation of adenovirus

Ultragenyx Pharmaceutical Inc. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11007261

Compositions and methods of vaccination against dengue virus in children and young adults

Takeda Vaccines, Inc. Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11008551

Method to increase the infectivity of virus particles

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11000561

Adeno-associated virus purification methods

Takeda Pharmaceutical Company Limited Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11001844

CRISPR/Cas-related methods and compositions for treating herpes simplex virus

Editas Medicine, Inc. Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11000593

Cellular or viral membrane coated nanostructures and uses thereof

The Regents of the University of California Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10993999

Materials and methods for producing improved lentiviral vector particles

IMMUNE DESIGN CORP. Β· Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10987354

Inhibitors of influenza virus replication and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10980872

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10961535

Compositions and agents against hepatitis B virus and uses thereof

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10961282

Variant adeno-associated viruses and methods of using

The Regents of the University of California Β· Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10960070

Prefusion coronavirus spike proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10953085

Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides,

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10954530

Retroviral and lentiviral vectors

AUTOLUS LIMITED Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10953083

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10952978

Hepatitis B antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10946080

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology Β· Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted